Endava is trading at $1.86, down 5.10%, after disclosing it will restate fiscal 2026 results.
- On October 28, 2026, Endava said an investigation found certain customer-supplier agreements were improperly accounted for.
- Estimated revenue adjustments equal 2%–4% of fiscal 2025 revenue; non-cash balance-sheet adjustments are expected to reduce adjusted profit before taxes.
- Several previously reported fiscal 2026-period results should no longer be relied upon.